phosphotyrosine has been researched along with su 11248 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abrams, TJ; Cherrington, JM; Lee, LB; Murray, LJ; Pryer, NK | 1 |
Coli, R; Deshmukh, GD; Diehl, W; DiNitto, JP; English, JM; Jacques, SL; Worrall, JW; Wu, JC; Zhang, Y | 1 |
Dembélé, P; Garnier, O; Martin, DK; Vilgrain, I | 1 |
3 other study(ies) available for phosphotyrosine and su 11248
Article | Year |
---|---|
SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Indoles; Lung Neoplasms; Mice; Mice, Nude; Phosphorylation; Phosphotyrosine; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Stem Cell Factor; Sunitinib; Tumor Cells, Cultured | 2003 |
Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.
Topics: Amino Acid Substitution; Antineoplastic Agents; Benzamides; Catalytic Domain; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Humans; Imatinib Mesylate; Indoles; Kinetics; Microchemistry; Models, Biological; Mutant Proteins; Peptide Mapping; Phosphorylation; Phosphotyrosine; Piperazines; Protein Binding; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Recombinant Fusion Proteins; Sunitinib | 2010 |
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
Topics: Animals; Antigens, CD; Cadherins; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Sunitinib; Tyrosine | 2022 |